Press releases worldwide
Familial risk of cardiac death: 28,000 children and adolescents screened in VRONI study. 250 cases with a genetic increase in risk of early heart attack identified and now undergoing treatment HerzFit app: 150,000 users use DigiMed Bayern tool for their […]
Biotechnology conference "BayOConnect" in Munich unites players from all areas of Bavarian and international biotechnology. With around 320 participants, 250 partnering meetings, 15 start-up pitches, 20 exhibitors and over 30 sponsors and partners, BioM successfully promotes networking in the industry. […]
Employment grows by 14% to 58,000 employees in the Bavarian biopharma sector Slight increase in the numbers of biopharma companies 11 start-ups and two relocations show start-up momentum Record financing of more than 470 million euros Oncology remains the […]
New innovative therapies and diagnostics will be developed in the future at the 900 m2 MAxL – by young start-up teams. MAxL provides founders state-of-the-art laboratory equipment, co-working, meeting and event spaces as well as numerous training and networking opportunities. […]
Eight pre-selected start-ups from medicine and life sciences pitched their business ideas at the 13th BioAngels Pitch Day hosted by BioM, the network organization of the Bavarian biotechnology. In just 12 minutes, founders presented scientific data and corporate strategy to […]
As part of this year’s BioTech Bootcamp of BioM Biotech Cluster Development GmbH and the life science business incubator "SmiLe Incubator" from Lund, Sweden, the international, eight-week training program for prospective founders and young companies climaxed in the Munich “Demo […]
On December 5, the DigiMed Bayern Symposium took place at the TranslaTUM of the Technical University of Munich. Under the headline "Big Data – Big Outcome?", high-profile presentations and discussions demonstrated that the intensive use of health data can make […]
More than 30 Bavarian biotech companies present medical solutions Munich is a unique ecosystem for globally successful biotechnology AI and health data increasingly decisive factor for innovative developments Bavarian biotechnology showed a strong presence at BIO-Europe from 6 to […]
. 5 million euros funding for innovative projects in biomedicine The research projects address the topics: Hepatitis-B, rheumatoid arthritis, urinary tract infections, success-optimized in vitro fertilization and bio-printers for human tissue models. Director General Sabine Jarothe praised the award winners […]
The Bavarian Ministry of Economic Affairs is funding the formation of the Munich Accelerator Life Sciences & Medicine (MAxL) in Munich-Martinsried with 8.5 million euros. The project for a new Bavarian incubator infrastructure for pre-seed projects and early-stage start-ups in […]